Agenus Inc. (AGEN) vs C4 Therapeutics, Inc. (CCCC)
A side-by-side comparison of Agenus Inc. and C4 Therapeutics, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
AGEN
Agenus Inc.
$8.73HealthcareDelayed quote: Oct 5, 2026, 4:00 PM EDT
CCCC
C4 Therapeutics, Inc.
$2.99HealthcareDelayed quote: Oct 5, 2026, 4:00 PM EDT
Total return — AGEN vs CCCC
growth of $100 · dividends reinvested · last 6yAGEN -89.2% (-31.0%/yr)CCCC -88.3% (-30.0%/yr)CCCC compounded faster over this window
AGEN CCCC
AGEN vs CCCC: by the numbers
- •AGEN is the larger company ($364M vs $331M market cap).
- •AGEN is profitable (69.34% net margin) while CCCC runs a net loss (-289.44%).
- •AGEN grew revenue faster over the past five years (14.13% vs 0.65% CAGR).
Metrics side by side
Valuation
| Metric | AGEN | CCCC |
|---|---|---|
| P/E ratio | 3.30 | N/A |
| Forward P/E | 32.64 | N/A |
| P/S ratio | 2.74 | 9.44 |
| P/B ratio | N/A | 1.34 |
| EV / EBITDA | 9.42 | N/A |
Profitability
| Metric | AGEN | CCCC |
|---|---|---|
| Gross margin | 29.63% | 77.81% |
| Operating margin | -18.00% | -290.68% |
| Net margin | 69.34% | -289.44% |
| ROE | N/A | -41.02% |
| ROIC | N/A | -35.92% |
Growth (annualized)
| Metric | AGEN | CCCC |
|---|---|---|
| Revenue CAGR (5Y) | 14.13% | 0.65% |
| Total return CAGR (5Y) | -40.10% | -41.77% |
Frequently asked
- Which has grown faster, AGEN or CCCC?
- Over the past five years, AGEN grew revenue faster — AGEN at a 14.13% CAGR versus CCCC at 0.65%.
- Is AGEN or CCCC more profitable?
- AGEN runs the higher net margin — AGEN at 69.34% versus CCCC at -289.44%.
- How have AGEN and CCCC total returns compared?
- Over the past 5 years, AGEN delivered -40.10% and CCCC delivered -41.77% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Agenus P/E ratioAgenus ROEC4 Therapeutics ROEAgenus operating marginC4 Therapeutics operating marginAgenus revenue growthC4 Therapeutics revenue growthAgenus free cash flowC4 Therapeutics free cash flow
Agenus & C4 Therapeutics appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.